Yale research redefines obesity as a chronic disease rather than a lack of willpower. New GLP-1 treatments and clinical ...

Neurodegenerative disorders such as Alzheimer's disease (AD) are typically diagnosed after irreversible pathology has developed. Aging, the strongest risk factor, drives molecular changes that ...

A protein that is a key modulator of fat, glucose and cholesterol levels in the body usually works in tandem with another ...

Sabab Hasan Khan, assistant research professor of biochemistry and molecular biology, is part of a Penn State research team that showed that a protein that is a key modulator of fat, glucose and ...

The mechanism for muscle stem cells repair could inspire therapeutics for muscle loss caused by injury, aging and weight-loss ...

Breast cancer patients should avoid fatty foods, warns a new study. Researchers found that a high-fat diet accelerates the growth and spread of breast cancer tumors.

Orforglipron, a novel oral nonpeptide GLP-1 receptor agonist (RA), led to a greater reduction in A1c and more significant weight loss compared to oral semaglutide in patients with type 2 diabetes (T2D ...

People Science today announced the publication of a randomized, double-blind, placebo-controlled clinical trial conducted with Mimio Health in Nature Scientific Reports, marking an important step ...

The warning from former FDA leadership is a reminder that we cannot outrun our own biology. While technology has advanced our food production, our internal systems remain rooted in the need for whole, ...

A protein that is a key modulator of fat, glucose and cholesterol levels in the body usually works in tandem with another ...